DigestRedComo funciona
Red
/
Empresas
Ta
No verificado

Takeda Pharmaceutical Company Limited

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

62 Comunicados de prensa

Ver todos los comunicados de prensa
22/09/2026
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
18/09/2026
Sanidad
Asociaciones/Profesionales
Farmacéutica
Medio Ambiente/Ecología
Biotecnología
Salud
Mercado laboral
Responsabilidad Social Corporativa
Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
14/09/2026
Industria
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
09/09/2026
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
28/08/2026
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
24/08/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
05/08/2026
Industria
Salud
Higiene alimentaria
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
30/07/2026
Web y redes sociales
Telefonía
Mercado de valores
Acciones y Obligaciones
Eventos
Oncología
Salud
Higiene alimentaria
Farmacéutica
Biotecnología
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
16/07/2026
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0
12/07/2026
Mercado laboral
Industria
Medicina - Varios
Material médico sanitario
Sanidad
Gestión empresarial
Biotecnología
Salud
Farmacéutica
Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
Fuente
Takeda Pharmaceutical Company Limited
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0